Chicago Capital, LLC Albireo Pharma, Inc. Transaction History

Chicago Capital, LLC

$3.56 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 20, 2023	BUY	$18.01 - $23.78 $4.37 Million - $5.77 Million	242,710 Added 21.67%	1,362,484 $0
Q3 2022 Oct 14, 2022	SELL	$16.32 - $26.37 $3.78 Million - $6.1 Million	-231,460 Reduced 17.13%	1,119,774 $21.7 Million
Q2 2022 Jul 21, 2022	BUY	$18.54 - $37.29 $6.29 Million - $12.7 Million	339,490 Added 33.55%	1,351,234 $26.8 Million
Q1 2022 Apr 21, 2022	BUY	$23.94 - $33.74 $3.89 Million - $5.48 Million	162,505 Added 19.14%	1,011,744 $30.2 Million
Q4 2021 Jan 20, 2022	BUY	$21.19 - $31.29 $625,126 - $923,086	29,501 Added 3.6%	849,239 $19.8 Million
Q3 2021 Oct 28, 2021	BUY	$27.36 - $35.98 $3.35 Million - $4.41 Million	122,502 Added 17.57%	819,738 $25.6 Million
Q2 2021 Jul 22, 2021	BUY	$28.9 - $36.87 $314,952 - $401,809	10,898 Added 1.59%	697,236 $24.5 Million
Q1 2021 Apr 13, 2021	BUY	$32.03 - $42.85 $2.18 Million - $2.92 Million	68,075 Added 11.01%	686,338 $24.2 Million
Q4 2020 Jan 25, 2021	BUY	$31.56 - $42.16 $3.4 Million - $4.55 Million	107,820 Added 21.12%	618,263 $23.2 Million
Q3 2020 Oct 13, 2020	BUY	$23.19 - $41.61 $190,876 - $342,491	8,231 Added 1.64%	510,443 $17 Million
Q2 2020 Jul 29, 2020	BUY	$14.82 - $29.92 $138,329 - $279,273	9,334 Added 1.89%	502,212 $13.3 Million
Q1 2020 Apr 21, 2020	BUY	$11.67 - $27.23 $3.71 Million - $8.65 Million	317,589 Added 181.18%	492,878 $8.07 Million
Q4 2019 Jan 14, 2020	SELL	$16.92 - $28.96 $799,639 - $1.37 Million	-47,260 Reduced 21.24%	175,289 $4.46 Million
Q3 2019 Oct 29, 2019	BUY	$20.0 - $31.88 $406,160 - $647,419	20,308 Added 10.04%	222,549 $4.45 Million
Q2 2019 Jul 11, 2019	BUY	$30.67 - $37.86 $393,588 - $485,857	12,833 Added 6.78%	202,241 $6.52 Million
Q1 2019 Apr 23, 2019	BUY	$22.22 - $32.21 $188,803 - $273,688	8,497 Added 4.7%	189,408 $6.1 Million
Q4 2018 Feb 11, 2019	BUY	$20.9 - $32.57 $431,856 - $672,993	20,663 Added 12.89%	180,911 $4.44 Million
Q3 2018 Nov 02, 2018	BUY	$29.29 - $36.87 $746,895 - $940,184	25,500 Added 18.92%	160,248 $5.28 Million
Q2 2018 Jul 19, 2018	BUY	$28.9 - $37.31 $1.27 Million - $1.64 Million	43,917 Added 48.35%	134,748 $4.78 Million
Q1 2018 May 09, 2018	BUY	$26.78 - $39.35 $2.43 Million - $3.57 Million	90,831 New	90,831 $2.96 Million

Others Institutions Holding ALBO

# of Institutions

Shares Held

865

Call Options Held

Put Options Held

View Full List

About ALBIREO PHARMA, INC.

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

More about ALBO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Capital, LLC with notifications on news.

Account